Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study — Meletios A Dimopoulos (2013) | RDL Network
Meletios A Dimopoulos, Sundar Jagannath, Sung‐Soo Yoon, David S. Siegel, Sagar Lonial, Roman Hájek, Thierry Façon, Laura Rosiñol, Hilary Blacklock, Hartmut Goldschmidt, Vânia Hungria, Andrew Spencer, Antonio Palumbo, Donna Reece, Thorsten Graef, Jennifer Houp, Linda Sun, Joseph Eid, Kenneth C. Anderson
David S. Siegel, Meletios A Dimopoulos, Sung‐Soo Yoon, Jacob P. Laubach, Jonathan L. Kaufman, Hartmut Goldschmidt, Donna Reece, Xavier Leleu, Simon Durrant, Fritz Offner, Michèle Cavo, Arnon Nagler, Sundar Jagannath, Thorsten Graef, Jennifer Houp, Linda Sun, J. Howe, Sandra Wear, Kenneth C. Anderson
David S. Siegel, Sundar Jagannath, Roman Hájek, Meletios A Dimopoulos, Sung‐Soo Yoon, Sagar Lonial, Jacob P. Laubach, Thorsten Graef, Dina Pietrangelo, Lisa Lupinacci, David Reiser, Kenneth C. Anderson
David S. Siegel, Meletios A Dimopoulos, Sundar Jagannath, Hartmut Goldschmidt, Simon Durrant, Jonathan L. Kaufman, Xavier Leleu, Arnon Nagler, Fritz Offner, Thorsten Graef, Joseph Eid, Jennifer Houp, Christine K. Gause, Scott Vuocolo, Kenneth C. Anderson
Discussion(0)
No comments yet. Be the first to comment.